Events contributing to the growth and progression of prostate carcinoma (CaP) are multifactorial. Angiogenesis is critical for tumour growth and is an early event following neoplastic transformation. Angiogenic factors facilitate neovascularisation by mediating vascular permeability, endothelial cell proliferation, protease expression, invasion, migration and capillary spatial remodelling. We studied to what extent these angiogenic processes are present in human CaP.
Microvessel hyperpermeability is an initiating event in angiogenesis. Hyperpermeability permits plasma proteins to leak into the surrounding matrix and facilitate further angiogenic processes. Hydraulic conductivity (Lp) is the experimental physiologic measurement of capillary permeability. Lp measurements in individually perfused intact rat mesenteric venular microvessels demonstrated that the application of vascular endothelial growth factor (VEGF, 10 nM) to rat mesenteric venular microvessels caused a 2.3 AE 0.2-fold increase in Lp (n 14). We hypothesised that human CaP cell lines express VEGF and cause microvessel hyperpermeability in vivo. To assess this, androgen-dependent orthotopically derived LnCaPLN3 cells, androgen-independent PC3M cells and control HS8 foreskin ®broblast cells had serum-free conditioned media (CM) collected, concentrated 100x and assayed for VEGF by ELISA. The VEGF concentrations in HS8, LNCaPLN3 and PC3M CM were 0.2, 5 and 4 nM respectively. To test the effect of cancer cell CM on microvessel permeability, intact rat mesenteric microvessels were cannulated and perfused individually with a micropipet. In each experiment, baseline Lp was measured ®rst with Ringer-albumin perfusate, then the same vessel was recannulated and perfused with cancer cell CM and changes in Lp were remeasured. We found that Lp increased 2.5 AE 0.3 times control with LNCapLN3 CM (n 4) and 4.3 AE 0.7 (n 4) times control with PC3M CM. In contrast, exposing microvessels to control CM (HS8) showed no signi®cant changes in Lp (n 4). These data suggest that prostate cancer-derived angiogenic cytokines increase microvessel permeability.
Basic ®broblast growth factor (bFGF) and VEGF are mitogenic for endothelial cell proliferation and stimulate urokinase type plasminogen activator (u-PA) expression. Tumour necrosis factor-a (TNF-a) causes apoptosis in CaP, but is also a potent inducer of u-PA expression. u-PA converts plasminogen to the potent protease plasmin, which degrades the surrounding matrix thereby facilitating endothelial cell migration. u-PA is inhibited by plasminogen activator inhibitor type-1 (PAI-1). We determined the expression of these angiogenic factors in human CaP by establishing epithelial and stromal primary cultures of surgically resected and pathologically veri®ed hyperplastic and malignant human prostate tissue. CM was generated for measuring bFGF, VEGF, u-PA, TNF-a, and PAI-1 by ELISA.
All primary prostate malignant and benign hyperplastic stromal cultures secreted bFGF, whereas the epithelial cultures did not. VEGF is expressed by primary BPH and malignant stromal cultures, but a 10-fold higher expression rate is measured in the corresponding epithelial cultures. Both u-PA and its inhibitor PAI-1 are highly secreted by tumour and hyperplastic epithelial components, and to a lesser extent by the stromal cells. TNF-a was not detected in CM from any of our primary cultures. However, following exposure to TNF-a, endothelial cells showed signi®cant induction of u-PA mRNA by Northern blotting. Therefore, we performed IHC on sections of BPH and CaP using a mouse anti-human TNF-a antibody to look for in vivo production of TNF-a. Signi®cant expression of TNF-a was noted from the secretory cells in CaP, and to a lesser extent in BPH.
We also sought to measure the ability of BPH and CaP cultures to generate angiostatin, a plasminogen fragment and known potent anti-angiogenic compound. It is produced following sulphydryl compound mediated cleavage of the ®fth kringle domain from plasmin. Thus, the expression of angiostatin from the pro-angiogenic protease plasmin is a closely linked event. BPH and CaP primary culture CM was collected and incubated with plasminogen and the resulting angiostatin cleavage product measured by Western blotting. Both BPH and tumour cultures demonstrated the ability to generate angiostatin.
In summary, both BPH and CaP express bFGF, VEGF, TNF-a, and u-PA. bFGF and VEGF induce endothelial cell proliferation and VEGF expressed by CaP results in capillary hyperpermeability, a critical early angiogenic step. u-PA and its inhibitor PAI-1 are present in this environment as well, contributing to neovascular invasion and remodelling. Both CaP and BPH tissue are able to convert plasminogen to angiostatin, an important step in regulating capillary tube formation.
